by Xcellerant Ventures | Sep 23, 2025 | Portfolio Company News
“Feasibility of Wave Health to monitor electronic patient-reported outcomes (ePROs) in prostate cancer patients” presents further findings Highlights Wave Health app achieved 93.3% ePRO compliance in collecting ePROs for inpatients with prostate cancer. Most patients...
by Xcellerant Ventures | Nov 18, 2024 | Portfolio Company News
Barcelona, Spain and El Segundo, California – Treatment Technologies & Insights, Inc. (TTI) parent company of the Wave Health digital health platform, today announced that ISPOR, the professional society for health economics and outcomes research, has...
by Tiffany Youtchoko | Nov 11, 2024 | Portfolio Company News
Lisbon, Portugal and El Segundo, CA – November 11 “PRO-WAVE1: Monitoring patient reported outcomes (PROs) in prostate cancer through Wave Health, a novel ePRO health platform” presents further findings on November 9, 2024. Lisbon, Portugal and El Segundo, CA...
by Xcellerant Ventures | Nov 11, 2024 | Portfolio Company News
Lisbon, Portugal and El Segundo, CA – November 11 “PRO-WAVE1: Monitoring patient reported outcomes (PROs) in prostate cancer through Wave Health, a novel ePRO health platform” presents further findings on November 9, 2024. Lisbon, Portugal and El Segundo, CA...
by Xcellerant Ventures | Aug 21, 2024 | Portfolio Company News
Origionally posted on Health Innovation Oxford’s website: https://www.healthinnovationoxford.org/our-work/strategic-and-industry-partnerships-2/economic-growth-case-studies/digital-health-oncology-platform-supports-better-outcomes-for-prostate-cancer-patients/...
